They proved that there was a distinct increase in the sialyl-Lewis X epitope (CESLEX). The sialyl-Lewis X epitope is reported to be a better indicator for breast cancer than the currently used biomarker, CA15-3, since CA15-3 is not a standalone marker [26]. CESLEX in combination with...
Moreover, there is no evidence yet for their ability to synthesize the type 1 chain. In particular, β3Gal-T3 was very recently reported as a GalNAc transferase involved in globoside biosynthesis and renamed β3GalNAc-T1 (15). β3Gal-T5, cloned from colon carcinoma cells, was found to ...